Author
Listed:
- Dingpeng Yang
(Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Ying Sun
(Capital Normal University)
- Jingjing Chen
(Nanjing Medical University)
- Ying Zhang
(Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences)
- Shuangshuang Fan
(Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences)
- Min Huang
(Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Xia Xie
(Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Yanni Cai
(Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences)
- Yafang Shang
(Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Tuantuan Gui
(Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine)
- Liming Sun
(Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Jiazhi Hu
(School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University)
- Junchao Dong
(Zhongshan School of Medicine, Sun Yat-sen University)
- Leng-Siew Yeap
(Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine)
- Xiaoming Wang
(Nanjing Medical University)
- Wei Xiao
(Capital Normal University)
- Fei-Long Meng
(Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
University of Chinese Academy of Sciences)
Abstract
Activation-induced cytidine deaminase (AID) initiates both antibody class switch recombination (CSR) and somatic hypermutation (SHM) in antibody diversification. DNA double-strand break response (DSBR) factors promote rearrangement in CSR, while translesion synthesis (TLS) polymerases generate mutations in SHM. REV7, a component of TLS polymerase zeta, is also a downstream effector of 53BP1-RIF1 DSBR pathway. Here, we study the multi-functions of REV7 and find that REV7 is required for the B cell survival upon AID-deamination, which is independent of its roles in DSBR, G2/M transition or REV1-mediated TLS. The cell death in REV7-deficient activated B cells can be fully rescued by AID-deficiency in vivo. We further identify that REV7-depedent TLS across UNG-processed apurinic/apyrimidinic sites is required for cell survival upon AID/APOBEC deamination. This study dissects the multiple roles of Rev7 in antibody diversification, and discovers that TLS is not only required for sequence diversification but also B cell survival upon AID-initiated lesions.
Suggested Citation
Dingpeng Yang & Ying Sun & Jingjing Chen & Ying Zhang & Shuangshuang Fan & Min Huang & Xia Xie & Yanni Cai & Yafang Shang & Tuantuan Gui & Liming Sun & Jiazhi Hu & Junchao Dong & Leng-Siew Yeap & Xiao, 2020.
"REV7 is required for processing AID initiated DNA lesions in activated B cells,"
Nature Communications, Nature, vol. 11(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16632-8
DOI: 10.1038/s41467-020-16632-8
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16632-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.